PRE TAX NTA |$3.78

Value as at close of business on 6 December 2024

New treatment giving severe COVID-19 patients a fighting chance

The Victor Chang Cardiac Research Institute featured on 7News discussing their latest Covid-19 project. This collaborative campaign, undertaken with St Vincent's Health Network Sydney, two hospitals in Victoria, and Mesoblast Limited has garnered much attention and showcases the great work that is underway in Australia's medical research community.

Watch the segment below:

 

Recent Posts

Read the latest insights
A curated list of HM1 investor updates, portfolio news and other interesting articles.
Read More
...